{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:07:40Z","timestamp":1761541660947,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1111\/jth.15803","type":"journal-article","created":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T09:04:05Z","timestamp":1656234245000},"page":"2012-2021","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["A personalized limited sampling approach to better estimate terminal half\u2010life of FVIII concentrates"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0167-4774","authenticated-orcid":false,"given":"Pierre","family":"Chelle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3331-8766","authenticated-orcid":false,"given":"Alfonso","family":"Iorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9014-1653","authenticated-orcid":false,"given":"Andrea N.","family":"Edginton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/jth.15803_bb0010","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1056\/NEJMoa067659","article-title":"Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia","volume":"357","author":"Manco\u2010Johnson","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.15803_bb0015","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1538-7836.2011.04214.x","article-title":"A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT study)","volume":"9","author":"Gringeri","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15803_bb0020","first-page":"1","article-title":"The pharmacokinetics of coagulation factors","volume":"12","author":"Lee","year":"2006","journal-title":"Haemophilia"},{"key":"10.1111\/jth.15803_bb0025","first-page":"1","article-title":"The use of pharmacokinetics in dose individualization of factor VIII in the treatment of hemophilia A","volume":"19","author":"McEneny\u2010King","year":"2016","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1111\/jth.15803_bb0030","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1111\/jth.13867","article-title":"Estimating and interpreting the pharmacokinetic profiles of individual patients with hemophilia A or B using a population pharmacokinetic approach: communication from the SSC of the ISTH","volume":"15","author":"Iorio","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15803_bb0035","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/hae.14046","article-title":"WFH Guidelines for the Management of Hemophilia. 3rd edition","volume":"26","author":"Srivastava","year":"2020","journal-title":"Haemophilia"},{"key":"10.1111\/jth.15803_bb0040","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/hae.13977","article-title":"Development and evaluation of the population pharmacokinetic models for FVIII and FIX concentrates of the WAPPS\u2010Hemo project","volume":"26","author":"Hajducek","year":"2020","journal-title":"Haemophilia"},{"key":"10.1111\/jth.15803_bb0045","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/psp4.12286","article-title":"Confidence and Prediction Intervals for Pharmacometric Models","volume":"7","author":"K\u00fcmmel","year":"2018","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1111\/jth.15803_bb0050","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.thromres.2018.08.004","article-title":"The effect of unmeasurable endogenous plasma factor activity levels on factor VIII dosing in patients with severe hemophilia A","volume":"170","author":"McEneny\u2010King","year":"2018","journal-title":"Thromb Res"},{"key":"10.1111\/jth.15803_bb0055","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/hae.14288","article-title":"Limited sampling strategies for accurate determination of extended half\u2010life factor VIII pharmacokinetics in severe haemophilia A patients","volume":"27","author":"McEneny\u2010King","year":"2021","journal-title":"Haemophilia"},{"key":"10.1111\/jth.15803_bb0060","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2516.2009.02191.x","article-title":"Limited blood sampling for pharmacokinetic dose tailoring of FVIII in the prophylactic treatment of haemophilia A","volume":"16","author":"Bjorkman","year":"2010","journal-title":"Haemophilia"},{"key":"10.1111\/jth.15803_bb0065","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/jth.13271","article-title":"Population pharmacokinetics of plasma\u2010derived factor IX: procedures for dose individualization","volume":"14","author":"Brekkan","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15803_bb0070","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1055\/a-1376-0970","article-title":"A practical, one\u2010clinic visit protocol for pharmacokinetic profile generation with the ADVATE myPKFiT dosing tool in severe hemophilia A subjects","volume":"121","author":"Blanchette","year":"2021","journal-title":"Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15803","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.15803","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622021122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622021122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15803","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:35:46Z","timestamp":1761536146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622021122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":13,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1538783622021122"],"URL":"https:\/\/doi.org\/10.1111\/jth.15803","relation":{},"ISSN":["1538-7836"],"issn-type":[{"type":"print","value":"1538-7836"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A personalized limited sampling approach to better estimate terminal half\u2010life of FVIII concentrates","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.15803","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}